Logo image
Definitions and outcome measures for bullous pemphigoid: Recommendations by an international panel of experts
Journal article   Peer reviewed

Definitions and outcome measures for bullous pemphigoid: Recommendations by an international panel of experts

Dedee F. Murrell, Benjamin S. Daniel, Pascal Joly, Luca Borradori, Masayuki Amagai, Takashi Hashimoto, Frederic Caux, Branka Marinovic, Animesh A. Sinha, Michael Hertl, …
Journal of the American Academy of Dermatology, Vol.66(3), pp.479-485
03/01/2012
DOI: 10.1016/j.jaad.2011.06.032
PMCID: PMC3883429
PMID: 22056920

View Online

Abstract

Our scientific knowledge of bullous pemphigoid (BP) has dramatically progressed in recent years. However, despite the availability of various therapeutic options for the treatment of inflammatory diseases, only a few multicenter controlled trials have helped to define effective therapies in BP. A major obstacle in sharing multicenter-based evidences for therapeutic efforts is the lack of generally accepted definitions for the clinical evaluation of patients with BP. Common terms and end points of BP are needed so that experts in the field can accurately measure and assess disease extent, activity, severity, and therapeutic response, and thus facilitate and advance clinical trials. These recommendations from the International Pemphigoid Committee represent 2 years of collaborative efforts to attain mutually acceptable common definitions for BP and proposes a disease extent score, the BP Disease Area Index. These items should assist in the development of consistent reporting of outcomes in future BP reports and studies. (J Am Acad Dermatol 2012;66:479-85.)
Dermatology Life Sciences & Biomedicine Science & Technology

Details

Logo image